All stocks ยท AARTIDRUGS
AD

Aarti Drugs Limited

AARTIDRUGS BSE Drug Manufacturers - Specialty & Generic Healthcare

Aarti Drugs Limited, through its subsidiaries, manufactures and markets active pharmaceutical ingredients (APIs), pharmaceutical intermediates, specialty chemicals, and formulations in India and internationally. The comโ€ฆ

ISIN INE767A01016
Listed โ€”
Quarters tracked 13
Filings 19 docs

About

Aarti Drugs Limited, through its subsidiaries, manufactures and markets active pharmaceutical ingredients (APIs), pharmaceutical intermediates, specialty chemicals, and formulations in India and internationally. The company offers aceclofenac, celecoxib, diclofenac sodium, diclodenac potassium, diclofenac diethylamine, diclofenac resinate, diclofenac epolamine, nimesulide, ciprofloxacin HCL, enrofloxacin base, gatifloxacin sesquihydrate, levofloxacin base, norfloxacin, ofloxacin, metronidazole, metronidazole benzoate, ornidazole, secnidazole, tinidazole, clopidogrel bisulphate, ticlopidine HCL, metformin HCL, pioglitazone HCL, teneligliptin, vildagliptin, fluconazole, ketoconazole, tolnaftate, zolpidem tartrate, niacin, raloxifene HCL, and acamprosate. It also provides benzene sulphonyl chloride, benzene sulphonic acid, methyl benzenesulfonate, sodium benzene sulfinate, para toluene sulphonyl chloride, methyl para toluenesulfonate, sodium para toluenesulfinate, para chlorobenzenesulfonyl chloride, formamide, calcium fluoride, potasium formate, benzenesulfonamide, ethyl p- toluenesulfonate, N,N',N'-tris-(4-toluene sulfonyl)-diethylenetriamine, ortho para toluene sulfonamides, ortho para toluene sulfonamides acid methyl ester, para chlorobenznesulfonamide, para toluenesulfonyl hydrazide, para toluenesulfonamide, and sodium benzenesulfonate. In addition, it offers pharma intermediate products, which includes Celecoxib, Ciprofloxacin, Clopidogrel, Diclofenac, Ketoconazole, Nimesulide, Raloxifene, Tinidazole, and Zolpidem. Further, the company develops drugs for antifungal, cardiovascular, and antidiabetic therapeutic areas, as well as non-steroidal anti-inflammatory drugs. The company was incorporated in 1984 and is headquartered in Mumbai, India.

Key Metrics

as of Sep 2026
Market Cap3,940 Cr
P/E20.40
Div Yield0.46 %
Book Valueโ‚น170.00
52w Highโ‚น535.00
52w Lowโ‚น319.00
Face Valueโ‚น10.00

Quarterly Results

Rs. Crores ยท hover row for definition
Metric Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023
Sales 703.00 720.00 602.00 653.00 591.00 677.00 557.00 598.00 555.00 620.00 606.00 642.00 661.00
Expenses 605.00 624.00 547.00 569.00 516.00 583.00 495.00 531.00 490.00 534.00 536.00 565.00 577.00
Operating Profit 98.00 96.00 55.00 84.00 74.00 93.00 62.00 67.00 65.00 86.00 70.00 76.00 84.00
OPM % 14.00 13.00 9.00 13.00 13.00 14.00 11.00 11.00 12.00 14.00 12.00 12.00 13.00
Other Income -1.00 1.00 1.00 0.00 0.00 2.00 12.00 1.00 1.00 1.00 2.00 1.00 1.00
Depreciation 18.00 18.00 18.00 16.00 15.00 15.00 14.00 14.00 13.00 14.00 13.00 13.00 13.00
Interest 9.00 8.00 9.00 8.00 9.00 9.00 9.00 9.00 9.00 9.00 8.00 8.00 9.00
Profit before tax 69.00 70.00 29.00 60.00 51.00 71.00 51.00 46.00 44.00 64.00 52.00 56.00 64.00
Tax % 28.00 21.00 -40.00 25.00 -6.00 12.00 27.00 24.00 24.00 26.00 29.00 30.00 24.00
Net Profit 50.00 55.00 41.00 45.00 54.00 63.00 37.00 35.00 33.00 47.00 37.00 40.00 48.00
EPS in Rs 5.50 6.05 4.44 4.96 5.91 6.89 4.06 3.84 3.62 5.15 3.99 4.31 5.17

Profit & Loss

Annual ยท Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Sales 2,565.002,387.002,529.002,716.002,489.002,155.001,806.001,561.001,244.001,195.001,140.001,097.00
Expenses 2,254.002,097.002,208.002,407.002,156.001,714.001,541.001,350.001,042.001,005.00960.00925.00
Operating Profit 312.00290.00321.00309.00333.00440.00266.00211.00202.00190.00180.00172.00
OPM % 12.0012.0013.0011.0013.0020.0015.0014.0016.0016.0016.0016.00
Other Income 2.0016.004.002.0011.005.006.006.001.004.000.001.00
Interest 36.0039.0038.0037.0024.0026.0037.0044.0038.0040.0048.0042.00
Depreciation 67.0056.0051.0050.0050.0050.0049.0043.0040.0038.0037.0031.00
Profit before tax 211.00212.00236.00224.00270.00369.00185.00131.00125.00116.0095.00100.00
Tax % 8.0021.0027.0026.0024.0024.0024.0032.0034.0029.0028.0023.00
Net Profit 195.00168.00172.00166.00205.00280.00141.0090.0082.0082.0069.0077.00
EPS in Rs 21.3618.4218.6517.9622.1430.0915.179.528.738.577.097.97
Dividend Payout % 9.005.005.006.005.008.003.003.003.003.0024.0041.00

Balance Sheet

Annual ยท Rs. Crores โ€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Equity Capital 91.0091.0092.0093.0093.0093.0023.0024.0024.0024.0024.0024.00
Reserves 1,458.001,278.001,190.001,100.00944.00820.00629.00520.00432.00376.00333.00284.00
Borrowings 577.00615.00564.00609.00543.00351.00389.00507.00546.00480.00483.00448.00
Other Liabilities 690.00591.00587.00620.00629.00502.00535.00405.00388.00311.00261.00248.00
Total Liabilities 2,815.002,575.002,432.002,421.002,208.001,766.001,576.001,455.001,389.001,191.001,102.001,004.00
Fixed Assets 1,086.00866.00811.00676.00690.00665.00644.00625.00602.00581.00493.00448.00
CWIP 214.00330.00261.00210.0077.0019.0012.0033.0028.0014.0034.0016.00
Investments 27.0022.0020.0019.0019.0017.0013.0012.0011.0012.005.005.00
Other Assets 1,488.001,356.001,340.001,516.001,422.001,064.00907.00785.00748.00584.00570.00534.00
Total Assets 2,815.002,575.002,432.002,421.002,208.001,766.001,576.001,455.001,389.001,191.001,102.001,004.00

Cash Flows

Annual ยท Rs. Crores โ€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Cash from Operating Activity 254.00245.00359.00133.0070.00155.00251.00143.0070.00175.00133.00105.00
Cash from Investing Activity -173.00-165.00-224.00-164.00-150.00-72.00-33.00-62.00-74.00-107.00-99.00-107.00
Cash from Financing Activity -77.00-82.00-136.0017.0092.00-81.00-215.00-80.004.00-68.00-33.001.00
Net Cash Flow 3.00-2.00-1.00-14.0013.002.002.001.000.000.001.00-1.00
Free Cash Flow 80.0067.00133.00-31.00-82.0078.00214.0080.00-5.0068.0034.00-2.00
CFO/OP % 80.00103.00131.0062.0046.0057.00110.0082.0047.00103.0085.0069.00

Ratios

Annual ยท Days / % โ€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Debtor Days 118.00115.00102.00116.00110.0094.0099.00107.00110.0091.00106.00105.00
Inventory Days 112.00114.00107.00101.00115.00117.00102.0086.00132.00100.0086.0082.00
Days Payable 109.00100.0094.0094.00103.0093.00104.0085.00123.0094.0090.0083.00
Cash Conversion Cycle 121.00129.00115.00123.00123.00118.0097.00109.00119.0097.00103.00104.00
Working Capital Days 76.0076.0074.0072.0063.0077.0054.0044.0033.0022.0019.0014.00
ROCE % 12.0013.0015.0015.0021.0034.0021.0017.0017.0018.0018.00โ€”

Shareholding Pattern

% holding โ€” latest first
Holder Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023
Promoters 54.43 55.03 55.03 54.72 55.23 55.48 55.38 55.64 55.67 57.13 57.47 58.57
FIIs 1.52 1.57 2.15 2.68 2.26 2.25 2.28 2.50 2.95 2.56 2.10 2.33
DIIs 10.29 10.22 10.12 9.90 9.94 9.70 8.77 7.83 7.35 5.99 5.26 5.32
Public 33.76 33.19 32.71 32.70 32.58 32.57 33.58 34.01 34.01 34.30 35.16 33.78
No. of Shareholders 143,476 144,946 148,363 152,252 160,260 169,761 176,006 190,281 150,218 157,547 170,414 167,446

Corporate Actions

50 records
ActionEx DateRecord DateRatioAmount (โ‚น)Notes
Dividend 09 Feb 2026 09 Feb 2026 โ€” 2.00
Dividend 04 Feb 2025 04 Feb 2025 โ€” 1.00
Other 05 Sep 2024 05 Sep 2024 โ€” โ€” Buy Back of Shares
Other 05 Sep 2024 05 Sep 2024 โ€” โ€” Buy Back
Dividend 06 Feb 2024 06 Feb 2024 โ€” 1.00
Other 04 Aug 2023 04 Aug 2023 โ€” โ€” Buy Back of Shares
Other 04 Aug 2023 04 Aug 2023 โ€” โ€” Buy Back
Dividend 08 Feb 2023 08 Feb 2023 โ€” 1.00
Dividend 09 Feb 2022 10 Feb 2022 โ€” 1.00
Other 30 Mar 2021 01 Apr 2021 โ€” โ€” Buy Back of Shares
Other 30 Mar 2021 01 Apr 2021 โ€” โ€” Buyback
Dividend 03 Nov 2020 04 Nov 2020 โ€” 2.50
Bonus 30 Sep 2020 01 Oct 2020 3:1 โ€”
Dividend 17 Feb 2020 18 Feb 2020 โ€” 2.00
Dividend 26 Jul 2019 โ€” โ€” 1.00
Other 28 Mar 2019 29 Mar 2019 โ€” โ€” Buy Back of Shares
Other 28 Mar 2019 29 Mar 2019 โ€” โ€” Buyback
Dividend 01 Aug 2018 โ€” โ€” 1.00
Other 18 Jan 2018 19 Jan 2018 โ€” โ€” Buy Back of Shares
Other 18 Jan 2018 19 Jan 2018 โ€” โ€” Buyback
Dividend 09 Aug 2017 โ€” โ€” 1.00
Other 01 Nov 2016 02 Nov 2016 โ€” โ€” Buy Back of Shares
Other 01 Nov 2016 02 Nov 2016 โ€” โ€” Buy Back
Other 13 Jul 2016 โ€” โ€” โ€” Annual General Meeting
Dividend 22 Mar 2016 24 Mar 2016 โ€” 3.00
Dividend 12 Feb 2016 15 Feb 2016 โ€” 1.50
Dividend 10 Nov 2015 14 Nov 2015 โ€” 2.25
Dividend 05 Aug 2015 โ€” โ€” 3.00
Bonus 24 Mar 2015 25 Mar 2015 1:1 โ€”
Dividend 04 Feb 2015 05 Feb 2015 โ€” 5.00
Dividend 19 Nov 2014 20 Nov 2014 โ€” 5.00
Dividend 02 Jul 2014 โ€” โ€” 5.50
Other 02 Jul 2014 โ€” โ€” โ€” Annual General Meeting/Dividend Rs:- 5.50 Per Share
Dividend 05 Feb 2014 06 Feb 2014 โ€” 4.50
Dividend 19 Nov 2013 20 Nov 2013 โ€” 3.00
Dividend 24 Jul 2013 โ€” โ€” 4.00
Dividend 11 Feb 2013 12 Feb 2013 โ€” 3.00
Dividend 05 Nov 2012 06 Nov 2012 โ€” 3.00
Dividend 17 Aug 2012 โ€” โ€” 3.00
Dividend 06 Feb 2012 07 Feb 2012 โ€” 2.00
Dividend 14 Jul 2011 โ€” โ€” 2.50
Dividend 07 Feb 2011 08 Feb 2011 โ€” 2.50
Dividend 18 Aug 2010 โ€” โ€” 5.00
Dividend 23 Jul 2009 โ€” โ€” 3.00
Dividend 13 Aug 2008 โ€” โ€” 1.80
Other 24 Aug 2007 โ€” โ€” โ€” Agm
Dividend 20 Mar 2007 21 Mar 2007 โ€” 1.20
Dividend 19 Jul 2006 โ€” โ€” 1.50
Dividend 27 Jul 2005 โ€” โ€” 1.60
Dividend 23 Oct 2001 08 Nov 2001 โ€” 1.00

Announcements

5 filings